Product Information
BUDESONIDE 0.25 MG/2 ML SUSP is a generic product labeled by Cipla USA Inc., priced at $0.6974 per ML under NDC 69097031887. Its NADAC has been published 452 times since Feb 7, 2018.
FDA first approved this application on Nov 16, 2017. Its Orange Book therapeutic-equivalence code is AN.
Strength
.25 mg/2mL
Manufacturer
Cipla USA Inc.NDC
69097031887
Classification
Generic
Dosage Form
INHALANT
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205710FDA Approved
11/16/2017
TE Code
AN
On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 0.25 MG/2 ML SUSP has been published 452 times since Feb 7, 2018, and over the history we have for it it has declined 57.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6974 per ML |
|---|---|
| All-time high | $1.6266 (Feb 14, 2018) |
| All-time low | $0.6798 (Oct 19, 2022) |
| 52-week high | $0.8041 |
| 52-week low | $0.6974 |
| Median price | $0.8478 |
| Average price | $0.8903 |
| Largest weekly change | +33.6% (Jul 19, 2023) |
| Weeks tracked | 452 |
| Tracking since | Feb 7, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 0.25 MG/2 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 0.25 MG/2 ML SUSP, manufactured by Cipla USA Inc., is $0.6974 per ML (NDC 69097031887), effective Sep 30, 2026.
How has the price of BUDESONIDE 0.25 MG/2 ML SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 0.25 MG/2 ML SUSP has declined 57.1%. It has been tracked across 452 weekly CMS publications since Feb 7, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 0.25 MG/2 ML SUSP?
Since Feb 7, 2018, the NADAC for BUDESONIDE 0.25 MG/2 ML SUSP has ranged from a low of $0.6798 (Oct 19, 2022) to a high of $1.6266 (Feb 14, 2018), with a median of $0.8478 per ML.
Are there cheaper alternatives to BUDESONIDE 0.25 MG/2 ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE 0.25 MG/2 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE 0.25 MG/2 ML SUSP?
BUDESONIDE 0.25 MG/2 ML SUSP (NDC 69097031887) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.